• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    How to manage atrial fibrillation secondary to ibrutinib

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    34396314.pdf
    Size:
    586.0Kb
    Format:
    PDF
    Description:
    From CORE
    Download
    Authors
    Essa, H.
    Lodhi, Taha
    Dobson, R.
    Wright, D
    Lip, G Y H
    Affiliation
    Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    None
    Citation
    Essa H, Lodhi T, Dobson R, Wright D, Lip GYH. How to Manage Atrial Fibrillation Secondary to Ibrutinib. JACC: CardioOncology. 2021 Mar;3(1):140–4.
    Journal
    JACC CardioOncology
    URI
    http://hdl.handle.net/10541/624526
    DOI
    10.1016/j.jaccao.2020.11.016
    PubMed ID
    34396314
    Additional Links
    https://dx.doi.org/10.1016/j.jaccao.2020.11.016
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.jaccao.2020.11.016
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Arrhythmia Patterns in Patients on Ibrutinib.
    • Authors: Fazal M, Kapoor R, Cheng P, Rogers AJ, Narayan SM, Wang P, Witteles RM, Perino AC, Baykaner T, Rhee JW
    • Issue date: 2021
    • Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.
    • Authors: Aw A, Brown JR
    • Issue date: 2017 Jul
    • Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
    • Authors: O'Riordan CE, Purvis GSD, Collotta D, Chiazza F, Wissuwa B, Al Zoubi S, Stiehler L, Martin L, Coldewey SM, Collino M, Thiemermann C
    • Issue date: 2019
    • Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.
    • Authors: Reda G, Fattizzo B, Cassin R, Mattiello V, Tonella T, Giannarelli D, Massari F, Cortelezzi A
    • Issue date: 2018 Jun 11
    • Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model.
    • Authors: Muqbil I, Chaker M, Aboukameel A, Mohammad RM, Azmi AS, Ramchandren R
    • Issue date: 2019 Aug
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.